ClinicalTrials.gov
public full text
Public Domain
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders#904342
- COMBINATII ( PERINDOPRIL ARGININA + INDAPAMID + AMLODIPINA ) TRIPLIXAM 5MG/ 1.25MG/ 5MG#166407
- Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine#1093040
- COMBINATII ( PERINDOPRIL ARGININA + INDAPAMID + AMLODIPINA ) TRIPLIXAM 5MG/ 1.25MG/ 10MG#166405
- Safety and PK/PD of RTA 1701 in Healthy Adults#857808
Record · ID 1139997
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive